WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2017192637) PHARMACEUTICAL COMPOSITION EFFECTIVE IN PREVENTING THE ADVERSE EFFECTS ASSOCIATED WITH THE PROLONGED USE OF DIHYDROFOLATE REDUCTASE INHIBITORS
Latest bibliographic data on file with the International Bureau    Submit observation

Pub. No.: WO/2017/192637 International Application No.: PCT/US2017/030711
Publication Date: 09.11.2017 International Filing Date: 03.05.2017
IPC:
A23L 33/15 (2016.01) ,A23L 33/175 (2016.01) ,A61K 31/525 (2006.01) ,A61K 31/714 (2006.01) ,A61K 31/685 (2006.01) ,A61K 31/4415 (2006.01)
Applicants: COMPANION THERAPEUTICS LLC[US/US]; Suite 118 1401 Sawgrass Corporate Parkway Sunrise, Florida 33323, US
Inventors: VILLAMIL TORRES, Julio Cesar; CO
REY FERRO, Camilo; US
Agent: MORALES, Joseph; US
Priority Data:
15/146,87404.05.2016US
Title (EN) PHARMACEUTICAL COMPOSITION EFFECTIVE IN PREVENTING THE ADVERSE EFFECTS ASSOCIATED WITH THE PROLONGED USE OF DIHYDROFOLATE REDUCTASE INHIBITORS
(FR) COMPOSITION PHARMACEUTIQUE EFFICACE POUR PRÉVENIR LES EFFETS INDÉSIRABLES ASSOCIÉS À L'UTILISATION PROLONGÉE D'INHIBITEURS DE LA DIHYDROFOLATE RÉDUCTASE
Abstract: front page image
(EN) The present invention relates to pharmaceutical compositions containing a combination of reduced forms of folate, liver protectors, vitamins, and essential or non-essential amino acids, useful in preventing the adverse effects associated with prolonged use of dihydrofolate reductase inhibitors.
(FR) La présente invention concerne des compositions pharmaceutiques contenant une combinaison de formes réduites de folate, de protecteurs hépatiques, de vitamines, et d'acides aminés essentiels ou non essentiels, utiles dans la prévention des effets indésirables associés à une utilisation prolongée d'inhibiteurs de la dihydrofolate réductase.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Office (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (EPO) (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG)
Publication Language: English (EN)
Filing Language: English (EN)